Nicholas A Zia Selected Research

alanyltyrosine

1/2020	Preclinical Evaluation of a High-Affinity Sarcophagine-Containing PSMA Ligand for 64Cu/67Cu-Based Theranostics in Prostate Cancer.
10/2019	A Bivalent Inhibitor of Prostate Specific Membrane Antigen Radiolabeled with Copper-64 with High Tumor Uptake and Retention.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicholas A Zia Research Topics

Disease

3	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 10/2019
3	Neoplasms (Cancer) 01/2020 - 01/2017

Drug/Important Bio-Agent (IBA)

3	AntigensIBA 01/2021 - 10/2019
2	Radioisotopes (Radionuclides)IBA 01/2021 - 01/2020
2	alanyltyrosineIBA 01/2020 - 10/2019
2	LigandsIBA 01/2020 - 10/2019
1	Serum AlbuminIBA 01/2020
1	Lysine (L-Lysine)FDA Link 10/2019
1	Copper-67IBA 10/2019
1	CopperIBA 10/2019
1	Copper-64IBA 10/2019
1	Glutamic Acid (Glutamate)FDA Link 10/2019
1	RadiopharmaceuticalsIBA 10/2019
1	EpitopesIBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	Contrast MediaIBA 01/2017

Therapy/Procedure

3	Therapeutics 01/2021 - 10/2019
2	Precision Medicine 01/2020 - 01/2017
1	Intravenous Administration 01/2020